Highlights

  • FY26 revenue reached AUD 111.9mn, a rise of 9% YoY, within the group guidance range of AUD 105mn–115mn.
  • The gross profit margin was 39.8%, compared with guidance of more than 40%.
  • United States sales grew 24% YoY in FY26.

During the trading session on 27 October 2026, Bubs Australia Limited (ASX:BUB) was trading at AUD 0.089, up 1.14%. Bubs Australia Limited (ASX:BUB) is a Australian infant nutrition producer and marketer selling formula and nutritional products in Australia and export markets. The company’s 27 August 2026 disclosure provides the latest developments discussed below; the trading movement is not attributed to that earlier disclosure.

Latest Development:

The company announcement dated 27 August 2026 addressed FY26 infant nutrition sales. It set out specific operating, financial or corporate information relevant to its reporting period. The principal figures and actions disclosed by Bubs Australia Limited (ASX:BUB) are reproduced below in the context in which the company presented them.

Reported Financial and Operating Measures

FY26 revenue reached AUD 111.9mn, a rise of 9% YoY, within the group guidance range of AUD 105mn–115mn. The gross profit margin was 39.8%, compared with guidance of more than 40%. The figures relate to the reporting period specified in the company release, rather than to the 27 October market session.

Operational Developments and Execution

United States sales grew 24% YoY in FY26. Inventory increased to AUD 36.3mn from AUD 20.1mn as the business prepared for demand. These activities were described in the announcement as company actions or operating developments; no separate share-price effect was stated.

Commercial Activities and Business Position

Tariff costs increased from AUD 0.3mn in 1HFY26 to AUD 2.3mn in 2HFY26. Regulatory-reset costs were AUD 3.9mn in 2HFY26, compared with none in 1HFY26. The announcement distinguished completed actions from management plans and proposals where relevant.

Guidance, Timetables and Further Disclosures

The company reported air freight costs of AUD 1.9mn in 1HFY26 and AUD 1.1mn in 2HFY26. Any future dates or targets in the statement represent the company’s announced schedule or expectations, not completed outcomes.

About the Company and Business Overview

Bubs Australia Limited (ASX:BUB) is a Australian infant nutrition producer and marketer selling formula and nutritional products in Australia and export markets. Its business activities provide the operating context for the 27 August 2026 announcement. The disclosure addresses business developments within this operating model, including the products, customers, assets or operational processes described in the sections above. The company’s commercial activity and reporting period should be distinguished from the intraday share quotation recorded on 27 October 2026.

Risks and Catalysts on Watch

Items identified in the release for future reporting include the cost items identified in the company announcement, the delivery of stated guidance and targets, the regulatory or approval steps specifically described. These are disclosure topics rather than forecasts of share-price performance. Future changes to the programme or financial measures would need to be assessed against subsequent company announcements. The market quotation set out in the introduction is an intraday observation only.

Key Developments to Follow

Bubs Australia Limited (ASX:BUB) has outlined its position through the 27 August 2026 company disclosure. The principal matters are the reported activity, quantified measures and any indicated next steps detailed above. Further company reports will establish whether announced initiatives have been completed and how reported metrics change in later periods. The 27 October 2026 intraday market data provides a separate point-in-time picture of trading in the company’s shares.